| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 561 | 595 | 588 | 655 | | Cost of Revenue | 286 | 148 | 269 | 303 | | | Gross Profit | 275 | 447 | 319 | 351 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,131 | 592 | 547 | 569 | | Non Recurring | (6,625) | 5,374 | 1,411 | 1,331 | | Others | 230 | 239 | 291 | 463 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (461) | (5,759) | (1,930) | (2,011) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | 30 | 47 | 116 | | Earnings Before Interest And Taxes | (2,173) | (4,562) | (1,455) | (1,895) | | Interest Expense | 282 | 442 | 365 | 397 | | Income Before Tax | (2,455) | (5,004) | (1,820) | (2,292) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 151 | 1,167 | 428 | 537 | | | | Net Income From Continuing Ops | (2,455) | (5,004) | (1,820) | (1,754) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 14 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (709) | (5,004) | (1,820) | (1,740) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($709) | ($5,004) | ($1,820) | ($1,740) |
|
0.51% Nasdaq 
0.03 (2.33%) 
Income Statement
